Chronic Cough Market: By Drug Class, By Route of Administration, By End Users and Region Forecast 2020-2031

download arrow download arrow Download Sample
settings arrow settings arrow email us

Chronic Cough Market Size, Share, Growth, Trends, and Global Industry Analysis: By Drug Class (Antihistamines, Corticosteroids, Decongestants, Combination Drugs, Antibiotics, Acid Blockers, and Others), By Route of Administration (Oral, Injections, Inhalations, and Others), By End Users (Hospitals, Clinics, Homecare, Others) and Region Forecast 2020-2031

checked icon checked icon arrow_drop_down
checked icon Single User License $4400 $3520
checked icon Multiple User License $6600 $5280
checked icon Corporate User License $8900 $7120

Chronic Cough Market size was valued at US$ 8,473 million in 2024 and is expected to reach US$ 14,521 million by 2031, growing at a significant CAGR of 8.0% from 2025-2031. A chronic cough is a cough that lasts eight weeks or longer, and the most common causes include tobacco use, postnasal drip, asthma, and acid reflux. Based on the drug class, the combination drugs segment is anticipated to dominate the market share over the forecast period.

According to the report from several studies, the worldwide prevalence of chronic cough was estimated as 9.6%, whereas the incidence rate ranged from 1.16 to 5.70 per 100 person-years. The rising prevalence of chronic cough and increased global healthcare expenditure will act as the market growth drivers. However, the high cost of treatment would be the lagging factor for the market. The development of novel technologies for diagnosis and novel drug development to treat chronic cough are opportunities for pharmaceutical companies for market expansion.

Key Developments:

  • In Oct 2019, Aurobindo Pharma received final approval from the US FDA to manufacture generic Guaifenesin extended-release tablets, for chronic cough.
  • In Jan 2022, the US FDA approved Merck’s Gefapixant, a non-narcotic, oral selective P2X3 receptor antagonist for the treatment of patients with unexplained chronic cough.

summary download arrow Download Sample

Chronic Cough Market Summary

Study Period

2025-2031

Base Year

2024

CAGR

8.0%

Largest Market

North-America

Fastest Growing Market

Asia-Pacific

Chronic Cough Market Dynamics

The various initiatives from pharmaceutical companies and governments towards launching more drugs for chronic cough will be major factors for the market expansion. For example, Nocion Therapeutics conducted a phase-I trial for cough in the USA for NOC 100. Whereas lack of training for healthcare professionals and product recalls could be the restraining factor for the market. For instance, in June 2020, GSK had to recall “Children’s Robitussin Honey Cough and Chest Congestion DM” and “Children’s Dimetapp Cold and Cough” due to “incorrect dosage cups”. Thus, the increased awareness, research, and development for chronic respiratory disorders will lead to the growth of the market within the forecast period.

Chronic Cough Market Segmentation Analysis

Report Benchmarks

Details

Report Study Period

2025-2031

Market Size in 2024

US$ 8,473 million

Market Size in 2031

US$ 14,521 million

Market CAGR

8.0%

By Drug Class

  • Antihistamines
  • Corticosteroids
  • Decongestants
  • Combination Drugs
  • Antibiotics
  • Acid Blockers
  • Others

By Route of Administration

  • Oral
  • Injections
  • Inhalations
  • Others

By End User

  • Hospitals
  • Clinics
  • Homecare
  • Others

By Region

  • North America (U.S., Canada)
  • Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
  • Asia-Pacific (China, India, Japan, Australia, Southeast Asia, Rest of Asia Pacific)
  • Latin America (Mexico, Brazil, Argentina, Columbia, Rest of Latin America)
  • Middle East & Africa (GCC, Egypt, Nigeria, South Africa, Rest of Middle East and Africa)

Key Features of the Report

  • The chronic cough market report provides granular level information about the market size, regional market share, historic market (2020-2024) and forecast (2025-2031)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
  • The report analyses the impact of the socio-political environment through PESTLE Analysis and competition through Porter Five Force Analysis.

Download Free Sample Report

I accept the Terms and Conditions,Disclaimers, GDPR Policy

Frequently Asked Questions

The chronic cough market size was valued at US$ 8,473 million in 2024 and is projected to grow at a significant CAGR of 8.0% from 2025-2031.

The development of novel technologies for diagnosis and novel drug development to treat chronic cough are the key opportunities for the market.

The rising prevalence of chronic cough and increased global healthcare expenditure are the growth drivers in the market.

Merck KGaA, Novartis AG, Johnson & Johnson Private Limited, Mylan N.V., Teva Pharmaceutical Industries Ltd., Sanofi, Sun Pharmaceutical Industries Ltd., Aurobindo Pharma, Biocon, Bristol-Myers Squibb Company, and GSK plc. are a few companies operating in the market.

Author image

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

1.Executive Summary
2.Global Chronic Cough Market Introduction 
2.1.Global Chronic Cough Market  - Taxonomy
2.2.Global Chronic Cough Market  - Definitions
2.2.1.Drug Class
2.2.2.Route of Administration
2.2.3.End User
2.2.4.Region
3.Global Chronic Cough Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Chronic Cough Market Analysis, 2020 - 2024 and Forecast 2025 - 2031
4.1.  Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Chronic Cough Market  By Drug Class, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million)
5.1. Antihistamines
5.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Corticosteroids
5.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Decongestants
5.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
5.4. Combination Drugs
5.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.4.3. Market Opportunity Analysis 
5.5. Antibiotics
5.5.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.5.3. Market Opportunity Analysis 
5.6. Acid Blockers
5.6.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
5.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.6.3. Market Opportunity Analysis 
5.7. Others
5.7.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
5.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.7.3. Market Opportunity Analysis 
6.Global Chronic Cough Market  By Route of Administration, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million)
6.1. Oral
6.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Injections
6.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Inhalations
6.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. Others
6.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
7.Global Chronic Cough Market  By End User, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million)
7.1. Hospitals
7.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Clinics
7.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Homecare
7.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
7.4. Others
7.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.4.3. Market Opportunity Analysis 
8.Global Chronic Cough Market  By Region, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million)
8.1. North America
8.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Europe
8.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Asia Pacific (APAC)
8.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Middle East and Africa (MEA)
8.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
8.5. Latin America
8.5.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.5.3. Market Opportunity Analysis 
9.North America Chronic Cough Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million)
9.1. Drug Class Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.Antihistamines
9.1.2.Corticosteroids
9.1.3.Decongestants
9.1.4.Combination Drugs
9.1.5.Antibiotics
9.1.6.Acid Blockers
9.1.7.Others
9.2.  Route of Administration Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Oral
9.2.2.Injections
9.2.3.Inhalations
9.2.4.Others
9.3.  End User Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.Hospitals
9.3.2.Clinics
9.3.3.Homecare
9.3.4.Others
9.4.  Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.4.1.United States of America (USA)
9.4.2.Canada
10.Europe Chronic Cough Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million)
10.1. Drug Class Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Antihistamines
10.1.2.Corticosteroids
10.1.3.Decongestants
10.1.4.Combination Drugs
10.1.5.Antibiotics
10.1.6.Acid Blockers
10.1.7.Others
10.2.  Route of Administration Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Oral
10.2.2.Injections
10.2.3.Inhalations
10.2.4.Others
10.3.  End User Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Hospitals
10.3.2.Clinics
10.3.3.Homecare
10.3.4.Others
10.4.  Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Germany
10.4.2.France
10.4.3.Italy
10.4.4.United Kingdom (UK)
10.4.5.Spain
11.Asia Pacific (APAC) Chronic Cough Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million)
11.1. Drug Class Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Antihistamines
11.1.2.Corticosteroids
11.1.3.Decongestants
11.1.4.Combination Drugs
11.1.5.Antibiotics
11.1.6.Acid Blockers
11.1.7.Others
11.2.  Route of Administration Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Oral
11.2.2.Injections
11.2.3.Inhalations
11.2.4.Others
11.3.  End User Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Hospitals
11.3.2.Clinics
11.3.3.Homecare
11.3.4.Others
11.4.  Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.China
11.4.2.India
11.4.3.Australia and New Zealand (ANZ)
11.4.4.Japan
11.4.5.Rest of APAC
12.Middle East and Africa (MEA) Chronic Cough Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million)
12.1. Drug Class Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Antihistamines
12.1.2.Corticosteroids
12.1.3.Decongestants
12.1.4.Combination Drugs
12.1.5.Antibiotics
12.1.6.Acid Blockers
12.1.7.Others
12.2.  Route of Administration Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Oral
12.2.2.Injections
12.2.3.Inhalations
12.2.4.Others
12.3.  End User Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Hospitals
12.3.2.Clinics
12.3.3.Homecare
12.3.4.Others
12.4.  Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.GCC Countries
12.4.2.South Africa
12.4.3.Rest of MEA
13.Latin America Chronic Cough Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million)
13.1. Drug Class Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Antihistamines
13.1.2.Corticosteroids
13.1.3.Decongestants
13.1.4.Combination Drugs
13.1.5.Antibiotics
13.1.6.Acid Blockers
13.1.7.Others
13.2.  Route of Administration Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Oral
13.2.2.Injections
13.2.3.Inhalations
13.2.4.Others
13.3.  End User Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Hospitals
13.3.2.Clinics
13.3.3.Homecare
13.3.4.Others
13.4.  Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Brazil
13.4.2.Mexico
13.4.3.Rest of LA
14. Competition Landscape
14.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
14.2.1.Merck KGaA
14.2.2.Novartis AG
14.2.3.Johnson & Johnson Private Limited
14.2.4.Mylan N.V.
14.2.5.Teva Pharmaceutical Industries Ltd.
14.2.6.Sanofi
14.2.7.Sun Pharmaceutical Industries Ltd.
14.2.8.Aurobindo Pharma
14.2.9.Biocon
14.2.10.Bristol-Myers Squibb Company
14.2.11.GSK plc.
14.2.12.NeRRe Therapeutics
15. Research Methodology 
16. Appendix and Abbreviations 

Key Market Players

  • Merck KGaA
  • Novartis AG
  • Johnson & Johnson Private Limited
  • Mylan N.V.
  • Teva Pharmaceutical Industries Ltd.
  • Sanofi
  • Sun Pharmaceutical Industries Ltd.
  • Aurobindo Pharma
  • Biocon
  • Bristol-Myers Squibb Company
  • GSK plc.
  • NeRRe Therapeutics

Related Industry Reports

Chronic Refractory Cough Market

Chronic Liver Disease Market

Chronic Bronchitis Market

Antibiotics Market